PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsGlobal Blood Therapeutics
Global Blood Therapeutics(GBT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OxbrytaVoxelotor2019-11-252032-2037
Anemia
,
Sickle cell anemia
,
Hemolytic anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voxelotor
renal insufficiency
,
liver diseases
,
hepatic insufficiency
,
healthy volunteers/patients
,
hypoxia
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
chronic renal insufficiency
,
kidney diseases
,
lung diseases
,
acute lung injury
,
lung injury
,
ulcer
,
leg ulcer
,
sickle cell anemia
,
anemia
Vitamin k
healthy volunteers/patients
,
colorectal neoplasms
,
thrombosis
,
venous thrombosis
,
venous thromboembolism
,
thromboembolism
,
heart diseases
,
rheumatic heart disease
,
rheumatic diseases
,
transcatheter aortic valve replacement
,
percutaneous coronary intervention
,
atrial fibrillation
,
pulmonary embolism
,
embolism
,
calcinosis
,
acute coronary syndrome
,
ischemic stroke
,
renal insufficiency
,
stroke
Menatetrenone
healthy volunteers/patients
,
thrombosis
,
venous thrombosis
,
venous thromboembolism
,
thromboembolism
,
atrial fibrillation
Retinol
neoplasms
,
breast neoplasms
,
carcinoma
,
triple negative breast neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
small cell lung carcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
pharyngeal neoplasms
,
peritoneal neoplasms
,
healthy volunteers/patients
,
head and neck neoplasms
,
atrial fibrillation
,
stomach neoplasms
,
ovarian neoplasms
,
pancreatic ductal carcinoma
,
biliary tract neoplasms
,
non-small-cell lung carcinoma
,
esophageal neoplasms
,
ocular hypertension
,
castration-resistant prostatic neoplasms
,
endometrial neoplasms
,
adenocarcinoma
,
lung neoplasms
,
pneumonia
,
lung injury
,
colorectal neoplasms
,
diabetes mellitus
,
type 1 diabetes mellitus
,
schizophrenia
,
psychotic disorders
,
mental disorders
,
metabolic diseases
,
calcium metabolism disorders
Carbendazim
psoriasis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use